{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:36:55Z","timestamp":1794062215255,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":104,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neuropharm.2022.109399","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:23:21Z","timestamp":1671621801000},"page":"109399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["The varieties of psychedelic law"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-9183","authenticated-orcid":false,"given":"Mason","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109399_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.yrtph.2011.01.006","article-title":"Harm potential of magic mushroom use: a review","volume":"59","author":"Amsterdam","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109399_bib2","first-page":"249","article-title":"Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis","volume":"10","author":"Badham","year":"1984","journal-title":"J. Ethnobotany."},{"key":"10.1016\/j.neuropharm.2022.109399_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin assisted Psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized trial","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109399_bib4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109399_bib5","article-title":"Denver becomes the first city to decriminalize hallucinogenic mushrooms","author":"Chavez","year":"2019","journal-title":"CNN"},{"key":"10.1016\/j.neuropharm.2022.109399_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14737175.2016.1220834","article-title":"Psilocybin for treating substance use disorders","volume":"17","author":"de Veen","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2022.109399_bib8","article-title":"\u2018People are dying\u2019 while state bureaucracy holds up Oregon treatment dollars, say Measure 110 proponents","author":"Green","year":"2022","journal-title":"Oregon Public Broadcasting"},{"key":"10.1016\/j.neuropharm.2022.109399_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109399_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bdi.13095","article-title":"An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: a case report","volume":"23","author":"Hendin","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2022.109399_bib12","article-title":"Washington state legislature approves $200,000 in psilocybin research funding in budget","author":"Jaeger","year":"2022","journal-title":"Marijuana Moment"},{"key":"10.1016\/j.neuropharm.2022.109399_bib13","article-title":"Again boosts 2022 production goals for psychedelics like psilocybin","author":"Jaeger","year":"2021","journal-title":"MDMA and DMT, Marijuana Moment"},{"key":"10.1016\/j.neuropharm.2022.109399_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/7854_2022_327","article-title":"Classic psychedelics in addiction treatment: the case for psilocybin in tobacco smoking cessation","volume":"56","author":"Johnson","year":"2022","journal-title":"Disruptive Psychopharmac."},{"key":"10.1016\/j.neuropharm.2022.109399_bib15","article-title":"Santa Cruz decriminalizes magic mushrooms and other natural psychedelics, making it the third US city to take such a step","author":"Kaur","year":"2020","journal-title":"CNN"},{"key":"10.1016\/j.neuropharm.2022.109399_bib16","article-title":"Oakland city Council effectively decriminalizes psychedelic mushrooms","author":"Kennedy","year":"2019","journal-title":"NPR"},{"key":"10.1016\/j.neuropharm.2022.109399_bib17","article-title":"Connecticut could open east coast's first psychedelic medicine centers","author":"Lekhtman","year":"2022","journal-title":"Filter"},{"key":"10.1016\/j.neuropharm.2022.109399_bib18","first-page":"69","article-title":"Psychedelic medicine for mental illness and substance use disorders: overcoming social and legal obstacles","volume":"21","author":"Marks","year":"2017","journal-title":"NYU J. Legislation. Pub. Pol."},{"key":"10.1016\/j.neuropharm.2022.109399_bib19","first-page":"649","article-title":"Controlled substance regulation for the COVID-19 mental health crisis","volume":"72","author":"Marks","year":"2020","journal-title":"Adm. Law Rev."},{"key":"10.1016\/j.neuropharm.2022.109399_bib20","article-title":"Warning: Oregon legalized supported adult use of psilocybin, not psychedelic therapy","author":"Marks","year":"2021","journal-title":"Chacruna"},{"key":"10.1016\/j.neuropharm.2022.109399_bib21","author":"Marks","year":"2022","journal-title":"Oregon Psilocybin Emails Show Secret Data Collection Plans Psychedelic Week"},{"key":"10.1016\/j.neuropharm.2022.109399_bib22","article-title":"Seeking psychedelics? Check the data privacy clause","author":"Marks","year":"2022","journal-title":"Wired"},{"key":"10.1016\/j.neuropharm.2022.109399_bib23","article-title":"Washington psilocybin bill would legalize supported adult use","author":"Marks","year":"2022","journal-title":"Harvard Law School Bill of Health"},{"key":"10.1016\/j.neuropharm.2022.109399_bib24","first-page":"1669","article-title":"Psychedelic therapy: a roadmap for wider acceptance and utilization","volume":"27","author":"Marks","year":"2021","journal-title":"Nat. Med. (N. Y., NY, U. S.)"},{"key":"10.1016\/j.neuropharm.2022.109399_bib25","first-page":"212","article-title":"Patents on psychedelics: the next legal battlefront of drug development","volume":"135","author":"Marks","year":"2022","journal-title":"Harvard Law Review Forum"},{"key":"10.1016\/j.neuropharm.2022.109399_bib26","unstructured":"Oregon Health Authority, Oregon Psilocybin \u2013 Facilitator License, https:\/\/www.oregon.gov\/oha\/PH\/PREVENTIONWELLNESS\/Pages\/Psilocybin-License-Facilitator.aspx."},{"key":"10.1016\/j.neuropharm.2022.109399_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted therapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109399_bib28","author":"Selsky","year":"2021","journal-title":"Oregon 1st state to decriminalize possession of drugs, AP News"},{"key":"10.1016\/j.neuropharm.2022.109399_bib29","article-title":"Psychedelic drug decriminalization bill gutted before crucial assembly vote","author":"Symon","year":"2022","journal-title":"California Globe"},{"key":"10.1016\/j.neuropharm.2022.109399_bib30","author":"Thomas"},{"key":"10.1016\/j.neuropharm.2022.109399_bib31","article-title":"Second statewide psychedelics measure fails to make November ballot","author":"Tiney","year":"2022","journal-title":"Denver Post"},{"key":"10.1016\/j.neuropharm.2022.109399_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-022-02205-w","article-title":"Psychedelic drugs take on depression","author":"Willyard","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109399_bib34","first-page":"1","article-title":"How will the DEA affect your clinical study?","volume":"1","author":"Woodworth","year":"2011","journal-title":"J. Clinical Research Best Practices"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:21:44Z","timestamp":1758439304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822004580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"alternative-id":["S0028390822004580"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109399","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The varieties of psychedelic law","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109399"}}